Emmanuelle Charpentier

Emmanuelle Charpentier is a Nobel Laureate (2020) who co-developed CRISPR-Cas9 with Jennifer Doudna. Her work on tracrRNA and its role in CRISPR-mediated immunity was essential to understanding how the system could be repurposed for genome editing. Charpentier continues fundamental research on bacterial systems with therapeutic potential.

Emmanuelle Charpentier是2020年诺贝尔奖获得者，与Jennifer Doudna共同开发了CRISPR-Cas9。她对tracrRNA及其在CRISPR介导的免疫中的作用的研究对于理解如何将该系统重新用于基因组编辑至关重要。Charpentier继续进行具有治疗潜力的细菌系统的基础研究。